Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Star Group
SGU
$423M
| $16.4M | ﹤0.01% |
1,874,305
-776,378
| -29% | -$6.12M |
|
1602
Helix Energy Solutions
HLX
$1.41B
| $16.4M | ﹤0.01% |
4,736,600
+746,900
| +19% | +$2.02M |
|
|
APLS
1603
DELISTED
Apellis Pharmaceuticals
APLS
| $16.3M | ﹤0.01% |
498,222
-20,312
| -4% | -$652K |
|
|
MDLA
1604
DELISTED
Medallia, Inc.
MDLA
| $16.2M | ﹤0.01% |
642,850
-618,750
| -49% | -$14.8M |
|
1605
Cyclerion Therapeutics
CYCN
$16.7M
| $16.2M | ﹤0.01% |
137,206
-1
| -0% | -$84 |
|
1606
James River Group Holdings
JRVR
$217M
| $16.1M | ﹤0.01% |
358,290
-28,080
| -7% | -$1.04M |
|
|
MTOR
1607
DELISTED
MERITOR, Inc.
MTOR
| $16.1M | ﹤0.01% |
810,755
-46,002
| -5% | -$850K |
|
1608
HF Sinclair
DINO
$14.5B
| $16M | ﹤0.01% |
549,190
-85,786
| -14% | -$2.55M |
|
1609
Emergent Biosolutions
EBS
$248M
| $16M | ﹤0.01% |
202,418
+202,362
| +361,361% | +$15.1M |
|
|
CXO
1610
DELISTED
CONCHO RESOURCES INC.
CXO
| $16M | ﹤0.01% |
310,067
-284,942
| -48% | -$15.7M |
|
|
COHR
1611
DELISTED
Coherent Inc
COHR
| $15.9M | ﹤0.01% |
121,366
-24,560
| -17% | -$3.21M |
|
1612
Perrigo
PRGO
$1.78B
| $15.8M | ﹤0.01% |
286,641
-400,696
| -58% | -$21.1M |
|
|
PE
1613
DELISTED
PARSLEY ENERGY INC
PE
| $15.8M | ﹤0.01% |
1,483,001
-1,893,269
| -56% | -$17.5M |
|
1614
Virgin Galactic
SPCE
$398M
| $15.8M | ﹤0.01% |
+48,430
| New | +$15.9M |
|
1615
US Physical Therapy
USPH
$1.22B
| $15.7M | ﹤0.01% |
193,323
+107,646
| +126% | +$7.85M |
|
|
BRSP
1616
BrightSpire Capital
BRSP
$648M
| $15.6M | ﹤0.01% |
2,226,068
-14,823
| -0.7% | -$75.9K |
|
1617
Health Catalyst
HCAT
$128M
| $15.6M | ﹤0.01% |
534,647
-554,187
| -51% | -$15.3M |
|
|
ZIXI
1618
DELISTED
Zix Corporation
ZIXI
| $15.5M | ﹤0.01% |
+2,250,000
| New | +$13.6M |
|
|
CTB
1619
DELISTED
Cooper Tire & Rubber Co.
CTB
| $15.4M | ﹤0.01% |
558,084
+22,572
| +4% | +$519K |
|
1620
RadNet
RDNT
$5.69B
| $15.4M | ﹤0.01% |
969,841
-1,030,566
| -52% | -$14.9M |
|
|
SFBS
1621
ServisFirst Bancshares
SFBS
$4.86B
| $15.4M | ﹤0.01% |
430,200
-45,200
| -10% | -$1.49M |
|
1622
ING
ING
$102B
| $15.3M | ﹤0.01% |
2,224,458
+831,454
| +60% | +$5.05M |
|
|
CLPR
1623
Clipper Realty
CLPR
$46.2M
| $15.3M | ﹤0.01% |
1,887,571
-663,799
| -26% | -$4.17M |
|
|
PRMW
1624
DELISTED
Primo Water Corporation
PRMW
| $15.2M | ﹤0.01% |
1,108,435
+925,735
| +507% | +$10.4M |
|
1625
Qualys
QLYS
$6.35B
| $15.2M | ﹤0.01% |
146,257
+145,663
| +24,522% | +$15.3M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.